Fig. 1: Downregulation of TRIM55 predicts poor clinical outcome in patients with HCC. | Cell Death Discovery

Fig. 1: Downregulation of TRIM55 predicts poor clinical outcome in patients with HCC.

From: TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90

Fig. 1: Downregulation of TRIM55 predicts poor clinical outcome in patients with HCC.

A The expression of TRIM55 in 103 pairs of HCC and corresponding adjacent nontumor tissues was examined by the immunohistochemistry (IHC) assay. The representative images were shown. B, C Kaplan–Meier survival analysis of the overall survival (B) and tumor-free survival (C) in the HCC patients based on TRIM55 expression. The low expression patients (n = 72) showed an expression value of HCC tissues less than the corresponding adjacent nontumor tissues, while the high expression patients (n = 31) showed the expression value of HCC tissues larger than the corresponding adjacent nontumor tissues. D The TCGA database analysis on the association between TRIM55 expression and overall survival.

Back to article page